These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28719177)

  • 1. Classics in Neuroimaging: Imaging the Dopaminergic Pathway with PET.
    Kanthan M; Cumming P; Hooker JM; Vasdev N
    ACS Chem Neurosci; 2017 Sep; 8(9):1817-1819. PubMed ID: 28719177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET radiotracers for molecular imaging in the brain: past, present and future.
    Zimmer L; Luxen A
    Neuroimage; 2012 Jun; 61(2):363-70. PubMed ID: 22222719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway.
    Murrell E; Pham JM; Sowa AR; Brooks AF; Kilbourn MR; Scott PJH; Vasdev N
    ACS Chem Neurosci; 2020 Jul; 11(14):2039-2044. PubMed ID: 32578977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases.
    Narayanaswami V; Drake LR; Brooks AF; Meyer JH; Houle S; Kilbourn MR; Scott PJH; Vasdev N
    ACS Chem Neurosci; 2019 Apr; 10(4):1867-1871. PubMed ID: 30789704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PET imaging for better understanding of normal and pathological neurotransmission].
    Zimmer L
    Biol Aujourdhui; 2019; 213(3-4):109-120. PubMed ID: 31829931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of clinical dopamine imaging.
    Lindsey KP; Gatley SJ
    Neuroimaging Clin N Am; 2006 Nov; 16(4):553-73, vii-viii. PubMed ID: 17148019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography.
    Sowa Dumond AR; Gross HK; Bohnen NI; Kanel P; Müller MLTM; Koeppe RA; Kilbourn MR; Scott PJH
    ACS Chem Neurosci; 2021 May; 12(9):1472-1479. PubMed ID: 33890459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Positron Emission Tomography Neuroimaging.
    Hooker JM; Carson RE
    Annu Rev Biomed Eng; 2019 Jun; 21():551-581. PubMed ID: 31167104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
    Walker MD; Volta M; Cataldi S; Dinelle K; Beccano-Kelly D; Munsie L; Kornelsen R; Mah C; Chou P; Co K; Khinda J; Mroczek M; Bergeron S; Yu K; Cao LP; Funk N; Ott T; Galter D; Riess O; Biskup S; Milnerwood AJ; Stoessl AJ; Farrer MJ; Sossi V
    J Parkinsons Dis; 2014; 4(3):483-98. PubMed ID: 25000966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 6-[(11)C]methyl-m-tyrosine ([(11)C]6MemTyr) for dopamine synthesis imaging in living brain using PET.
    Kanazawa M; Ohba H; Iwazaki A; Kakiuchi T; Tsukada H
    Bioorg Med Chem; 2015 Feb; 23(4):729-34. PubMed ID: 25596169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging I.
    Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):xi-xiii. PubMed ID: 15488552
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of PET neuroimaging.
    Nasrallah I; Dubroff J
    Semin Nucl Med; 2013 Nov; 43(6):449-61. PubMed ID: 24094712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear medicine procedures in the diagnosis of NET: a historical perspective.
    Maffione AM; Karunanithi S; Kumar R; Rubello D; Alavi A
    PET Clin; 2014 Jan; 9(1):1-9. PubMed ID: 25029929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography: ligand imaging.
    Moghbel M; Newberg A; Alavi A
    Handb Clin Neurol; 2016; 135():229-240. PubMed ID: 27432668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history of cerebral PET scanning: from physiology to cutting-edge technology.
    Portnow LH; Vaillancourt DE; Okun MS
    Neurology; 2013 Mar; 80(10):952-6. PubMed ID: 23460618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.